#United States #Cancer Research #Bronx #Montefiore Cancer Center #Ulrich Steidl

Advancements in Cancer Research: New Leadership at MECCC

The Montefiore Einstein Comprehensive Cancer Center (MECCC) has ushered in a new era in cancer research and treatment with the formation of an experienced leadership team. Appointed by Dr. Ulrich Steidl, who took the helm as Director and Vice President of Cancer Medicine at Montefiore Einstein just six months ago, this team is poised to enhance various aspects of cancer care—ranging from basic and clinical research to population science, all while tackling the pressing issues of cancer health disparities.

Dr. Steidl expressed his enthusiasm about the newly appointed leaders, noting their exceptional qualifications and accomplishments in the field. He stated, "Today marks a new chapter as we elevate elite colleagues who have significant research accomplishments and leadership experience to principal posts at MECCC. They are recognized 'all-stars' in their fields."

Meet the Key Figures of the New Team

Amit K. Verma, M.D., M.B.B.S.

Dr. Verma, who serves as Chair of Medical Oncology, is now the Deputy Director of MECCC. A leading expert in myeloid malignancies, Dr. Verma has significantly contributed to our understanding of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). His research led to novel FDA-approved therapies, demonstrating his commitment to transforming cancer treatment through innovative research. Recently, he received an